LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Начало・Списък с акции・Essa Pharma Inc

Essa Pharma Inc

Затворен

1.92

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.83

Максимум

1.92

Ключови измерители
By Trading Economics
Приходи	2.4M -4M
EPS	-0.14
Служители	35
EBITDA	2.2M -6.4M

Пазарни показатели
By TradingEconomics
Пазарна капитализация	5.7M 90M
Предишно отваряне	1.92
Предишно затваряне	1.92

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

1.7 / 1.72 Подкрепа & съпротива

Essa Pharma Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.08.2025 г., 23:09 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22.08.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22.08.2025 г., 21:23 ч. UTC

Пазарно говорене

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22.08.2025 г., 21:18 ч. UTC

Пазарно говорене

US Economic Growth Seen Slowing This Year -- Market Talk

22.08.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

U.S. Takes 10% Stake in Intel -- Barrons.com

22.08.2025 г., 21:03 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

22.08.2025 г., 21:03 ч. UTC

Пазарно говорене

Mexican Stocks Close At Record High -- Market Talk

22.08.2025 г., 20:58 ч. UTC

Пазарно говорене

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22.08.2025 г., 20:57 ч. UTC

Придобивния, сливания и поглъщания

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22.08.2025 г., 20:56 ч. UTC

Печалби

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22.08.2025 г., 20:55 ч. UTC

Печалби

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

22.08.2025 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

22.08.2025 г., 20:41 ч. UTC

Придобивния, сливания и поглъщания

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22.08.2025 г., 20:24 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22.08.2025 г., 20:16 ч. UTC

Придобивния, сливания и поглъщания

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22.08.2025 г., 19:19 ч. UTC

Пазарно говорене

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22.08.2025 г., 19:10 ч. UTC

Пазарно говорене

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22.08.2025 г., 19:06 ч. UTC

Пазарно говорене

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22.08.2025 г., 19:03 ч. UTC

Пазарно говорене

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22.08.2025 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Сравнение с други в отрасъла

Ценова промяна

Essa Pharma Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Essa Pharma Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.7 / 1.72Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.